Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Xenon vs TIVA for Propofol Consumption in ASA III Patients
NCT00919126Phase 3Terminated
- Sponsor
- Air Liquide
- Start
- Jun 2009
- Primary completion
- Jan 2012
- Modality
- Small Molecules
- Countries
- 3
01
Overview
A Phase 3 trial of xenon in general anesthesia, sponsored by Air Liquide. Started Jun 2009; status: terminated.
02
Drugs
xenon
03
Conditions
general anesthesia
Beyond the preview
Go deeper on NCT00919126.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00919126.